Hearing on “Examining HRSA’s Oversight of the 340B Drug Pricing Program,” Subcommittee on Oversight and Investigations (July 18, 2017)
The Subcommittee on Oversight and Investigations held a hearing on Tuesday, July 18, 2017, at 10:15 a.m. in 2322 Rayburn House Office Building. The hearing is entitled “Examining HRSA’s Oversight of the 340B Drug Pricing Program.”
Livestream
Key Documents
Memorandum from Ranking Member Pallone to the Subcommittee on Oversight and Investigations
Opening Statement of Ranking Member Pallone as prepared for delivery
Witnesses
Krista M. Pedley, PharmD, MS, Captain, USPHS
Director
Office of Pharmacy Affairs
Health Resources and Services Administration
U.S. Department of Health and Human Services
Debra Draper
Director, Health Care
U.S. Government Accountability Office
Erin Bliss
Assistant Inspector General
Office of Evaluation and Inspections
Office of Inspector General
U.S. Department of Health and Human Services